Modeling methods for facilitating decisions in pharmaceutical policy and population therapeutics

被引：5

作者：

Patten, SB

Lee, RC

机构：

[1] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 4N1, Canada

[2] Univ Calgary, Dept Psychiat, Calgary, AB T2N 4N1, Canada

[3] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 2T9, Canada

[4] Foothills Med Ctr, Calgary Hlth Reg, Hlth Technol Implementat Unit, Calgary, AB T2N 2T9, Canada

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2002年 / 11卷 / 02期

关键词：

D O I：

10.1002/pds.706

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

[No abstract available]

引用

页码：165 / 168

页数：4

共 26 条

[1] THE MARKOV PROCESS IN MEDICAL PROGNOSIS [J].

BECK, JR ;

PAUKER, SG .

MEDICAL DECISION MAKING, 1983, 3 (04) :419-458

[2]

Bender E. A., 2000, INTRO MATH MODELING

[3] Primer on medical decision analysis .2. Building a tree [J].

Detsky, AS ;

Naglie, G ;

Krahn, MD ;

Redelmeier, DA ;

Naimark, D .

MEDICAL DECISION MAKING, 1997, 17 (02) :126-135

[4] Primer on medical decision analysis .1. Getting started [J].

Detsky, AS ;

Naglie, G ;

Krahn, MD ;

Naimark, D ;

Redelmeier, DA .

MEDICAL DECISION MAKING, 1997, 17 (02) :123-125

[5] Two stage model for carcinogenesis: number and size distributions of premalignant clones in longitudinal studies [J].

Dewanji, A ;

Goddard, MJ ;

Krewski, D ;

Moolgavkar, SH .

MATHEMATICAL BIOSCIENCES, 1999, 155 (01) :1-12

[6] A STOCHASTIC 2-STAGE MODEL FOR CANCER RISK ASSESSMENT .2. THE NUMBER AND SIZE OF PREMALIGNANT CLONES [J].

DEWANJI, A ;

VENZON, DJ ;

MOOLGAVKAR, SH .

RISK ANALYSIS, 1989, 9 (02) :179-187

[7]

Gold MR, 1996, COST EFFECTIVENESS H

[8] FACTORED STOCHASTIC TREES - A TOOL FOR SOLVING COMPLEX TEMPORAL MEDICAL DECISION-MODELS [J].

HAZEN, GB .

MEDICAL DECISION MAKING, 1993, 13 (03) :227-236

[9] STOCHASTIC TREES - A NEW TECHNIQUE FOR TEMPORAL MEDICAL DECISION MODELING [J].

HAZEN, GB .

MEDICAL DECISION MAKING, 1992, 12 (03) :163-178

[10]

Hoppensteadt FC, 1992, MATH MED LIFE SCI

← 1 2 3 →